Enzyme Inhibition: Irreversible vs Allosteric
Enzyme Inhibition - Overview
Enzyme inhibitors are molecules that decrease or block enzyme activity. They are generally
classified into:
- Reversible inhibitors (competitive, non-competitive, uncompetitive)
- Irreversible inhibitors
- Allosteric inhibitors
1. Irreversible Inhibition
Definition:
Irreversible inhibition occurs when an inhibitor binds permanently to an enzyme, usually forming
covalent bonds.
Mechanism:
- Inhibitor forms covalent bond at the active site
- Enzyme activity is permanently lost
Key Characteristics:
- Binding type: Covalent
- Reversibility: Irreversible
- Effect on Vmax: Decreases
- Effect on Km: Variable
- Recovery: Only by new enzyme synthesis
Examples:
- Aspirin (inhibits COX enzyme)
- Penicillin (inhibits transpeptidase)
- Organophosphates (inhibit acetylcholinesterase)
- Iodoacetate (inhibits glycolytic enzyme)
2. Allosteric Inhibition
Definition:
Allosteric inhibition occurs when an inhibitor binds to a site other than the active site, altering the
enzyme's shape.
Mechanism:
- Non-covalent binding at allosteric site
- Conformational change reduces enzyme activity
Key Characteristics:
- Binding site: Allosteric site
- Binding type: Non-covalent
- Reversibility: Reversible
- Effect on Vmax: Decreases
- Effect on Km: May or may not change
- Role: Feedback regulation
Examples:
- ATP (inhibits PFK-1 in glycolysis)
- CTP (inhibits aspartate transcarbamoylase)
- Isoleucine (inhibits threonine deaminase)
Irreversible vs Allosteric Inhibition - Comparison
Feature | Irreversible Inhibition | Allosteric Inhibition
---------------------|-----------------------------|------------------------------
Binding Site | Active site | Allosteric site
Bond Type | Covalent | Non-covalent
Reversibility | No | Yes
Effect on Enzyme | Permanently inactivates | Temporarily reduces activity
Physiological Role | Drug-related or toxic | Regulatory (metabolism)
Recovery | New enzyme needed | Reversible after removal